secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2023-08-03T23:59:59+00:00
Accession:  0001193125-23-202850
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed Q4 FY2023 revenue up 23% to $1.12B; EPS $1.56 GAAP, dividend raised 9% to $0.48
--------------------------------------------------------------------------------

- Revenue $1,122.1M +23% YoY; GAAP diluted EPS $1.56 (+17%), non-GAAP $1.60 (+7%).
- Full-year revenue $4,223.0M (+18%); GAAP EPS $6.09 (+15%), non-GAAP $6.44 (+11%).
- Gross margin contracted 210 bps to 55.0% (GAAP) and 200 bps to 55.8% (non-GAAP).
- Quarterly dividend raised 9% to $0.48/share; record Aug 17, payable Sept 21, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312523202850/0001193125-23-202850-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312523202850/d510491d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-202850

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer